Voyager Therapeutics, Inc. VYGR 31.17
Health Care · NASDAQ · Data as of 2026-08-06
Voyager Therapeutics, Inc. (VYGR) has delivered +25.1% annualized revenue growth, n/a earnings growth, and n/a dividend growth over 10 years of data. Ranked #1807 of 1968 stocks overall and #233 of 260 in the Health Care sector by Steady Score.
Industry
Biological Products
Steady Score
31.17
Overall Rank
#1807 / 1968
Sector Rank
#233 / 260
Revenue CAGR
+25.1%
Earnings CAGR
-
Dividend CAGR
-
?
E/R CAGR Ratio
-
Revenue
Earnings
Dividends
Free Cash Flow
Margin
NET Margin
FCF Margin
Payout Ratio
Payout Ratio
FCF Payout Ratio